Akanda (AKAN) Stock Price, News & Analysis

Company Overview

Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products to patients worldwide. It offers medicinal-grade cannabis and cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.

Key Stats

• Today's Range: $3.65 to $3.99
• 50-Day Range: $3.28 to $4.53
• 52-Week Range: $2.91 to $8.75
• Volume: 39,860 shs
• Average Volume: 53,038 shs
• Market Capitalization: $1.69 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Akanda Stock Analysis - MarketRank™

Akanda scored higher than 17% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Akanda.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Book Value per Share Ratio

Akanda has a P/B Ratio of 0.41. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.11% of the float of Akanda has been sold short.

Short Interest Ratio / Days to Cover

Akanda has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Akanda has recently increased by 48.24%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Akanda does not currently pay a dividend.

Dividend Growth

Akanda does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

1.11% of the float of Akanda has been sold short.

Short Interest Ratio / Days to Cover

Akanda has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Akanda has recently increased by 48.24%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 2.3 / 5
• News Sentiment: 0.09

News Sentiment

Akanda has a news sentiment score of 0.09. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.03 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 7 news articles for Akanda this week, compared to 0 articles on an average week.

MarketBeat Follows

1 people have added Akanda to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Akanda insiders have not sold or bought any company stock.

Percentage Held by Insiders

20.39% of the stock of Akanda is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 1.00% of the stock of Akanda is held by institutions.

AKAN Stock Analysis - Frequently Asked Questions

How have AKAN shares performed this year?

Akanda's stock was trading at $5.00 at the beginning of the year. Since then, AKAN stock has decreased by 23.6% and is now trading at $3.8210.

When did Akanda's stock split?

Shares of Akanda reverse split on the morning of Thursday, May 23rd 2024.The 1-40 reverse split was announced on Thursday, May 23rd 2024. The number of shares owned by shareholders was adjusted after the market closes on Thursday, May 23rd 2024. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

When did Akanda IPO?

Akanda (AKAN) raised $16 million in an initial public offering (IPO) on Tuesday, March 15th 2022. The company issued 4,000,000 shares at a price of $4.00 per share.

How do I buy shares of Akanda?

Shares of AKAN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Akanda own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Akanda investors own include Pacific Biosciences of California (PACB), Tilray Brands (TLRY), Recursion Pharmaceuticals (RXRX), Editas Medicine (EDIT), SoundHound AI (SOUN), Mobile-health Network Solutions (MNDR) and Ginkgo Bioworks (DNA).

Company Calendar

• Today: 8/29/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:AKAN
• CIK: 1888014
• Web: www.akandacorp.com
• Phone: 44-20-3488-9514
• Fax: N/A
• Employees: 110
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.39
• Quick Ratio: 1.39

Sales & Book Value

• Annual Sales: $840 thousand
• Price / Sales: 2.08
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $9.37 per share
• Price / Book: 0.41

Miscellaneous

• Outstanding Shares: 460,000
• Free Float: 364,000
• Market Cap: $1.75 million
• Optionable: Not Optionable
• Beta: 1.59